The downwards trendline is showing signs of cracks and buying on weakness presents an excellent risk reward opportunity on HTBX that has just filed a patent application for a lung cancer inhibitor.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。